Table 4. Clinical feature of 21 cases with postoperative CSF leakage.
Leak No. | Gender | Age | Pathology | Surgery | Leak grade | Systemic disease | Smoking | RT | Pedicled flap | Dural substitute | Buttress | POD | Meningitis | Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 52 | Pituitary adenoma | Primary | 2 | (-) | (-) | (-) | (-) | SDS | SB | 14 | (+) | Revise repair |
2 | F | 77 | Pituitary adenoma | Revision | 2 | HTN | (-) | (-) | NSF | SDS | SB | 3 | (+) | Revise repair |
3 | F | 77 | Pituitary adenoma | Revision | 2 | HTN | (-) | (-) | NSF | SDS | SB | 6 | (+) | Revise repair |
4 | F | 44 | Meningioma | Primary | 1 | (-) | (-) | (-) | (-) | SDS | (-) | 12 | (-) | Revise repair |
5 | F | 28 | Pituitary adenoma | Revision | 2 | NF | (-) | (-) | (-) | SDS | SC | 6 | (-) | Revise repair |
6 | M | 57 | Pituitary adenoma | Revision | 3 | (-) | (-) | (+) | (-) | SDS | SB | 7 | (+) | Revise repair |
7 | M | 57 | Pituitary adenoma | Revision | 3 | (-) | (-) | (+) | NSF | SDS | SB | 101 | (+) | Revise repair |
8 | M | 31 | Craniopharyngioma | Primary | 3 | (-) | (+) | (-) | NSF | SDS | SB | 26 | (+) | Revise repair |
9 | M | 33 | Craniopharyngioma | Revision | 3 | (-) | (-) | (+) | NSF | SDS | SB | 12 | (-) | Revise repair |
10 | F | 60 | Epidermoid cyst | Primary | 3 | (-) | (-) | (-) | NSF | (-) | SB | 25 | (+) | Revise repair |
11 | M | 32 | Craniopharyngioma | Primary | 2 | (-) | (+) | (-) | (-) | (-) | SB | 6 | (-) | Revise repair |
12 | F | 28 | Craniopharyngioma | Primary | 3 | (-) | (-) | (-) | NSF | (-) | (-) | 10 | (+) | Revise repair |
13 | F | 59 | Pituitary adenoma | Revision | 1 | HTN | (-) | (-) | MTF | Fat | (-) | 3 | (+) | Revise repair |
14 | F | 56 | Craniopharyngioma | Revision | 1 | (-) | (-) | (-) | (-) | Fat | (-) | 8 | (-) | Revise repair |
15 | F | 56 | Craniopharyngioma | Revision | 2 | (-) | (-) | (-) | NSF | Fat | (-) | 20 | (-) | Revise repair |
16 | F | 56 | Craniopharyngioma | Revision | 1 | (-) | (-) | (-) | (-) | Fat | SB | 12 | (-) | Revise repair |
17 | F | 53 | Pituitary adenoma | Primary | 1 | (-) | (-) | (-) | (-) | (-) | (-) | 4 | (-) | Revise repair |
18 | F | 53 | Pituitary adenoma | Primary | 2 | (-) | (-) | (-) | NSF | SDS | SB | 14 | (+) | Revise repair |
19 | M | 79 | Craniopharyngioma | Primary | 3 | DM,CVD | (+) | (-) | NSF | (-) | (-) | 4 | (+) | Revise repair |
20 | M | 79 | Craniopharyngioma | Revision | 3 | DM,CVD | (+) | (-) | NSF | Fat | (-) | 5 | (+) | Revise repair |
21 | F | 50 | Rathke’s cleft cyst | Primary | 1 | (-) | (-) | (-) | (-) | (-) | (-) | 5 | (+) | Revise repair |
HTN, hypertension; NF, neurofibromatosis; CVD, cardiovascular disease; NSF, nasoseptal flap; MTF, middle turbinate flap; SDS, synthetic dural substitute; SB, septal bone (vomer); SC, septal cartilage.